International Iberian Nanotechnology Laboratory , in Braga, Portugal, a fully international research organization in Europe in the field of nanoscience and nanotechnology. INL is the result of a joint decision of the Governments of Portugal and Spain, taken on November 19, 2005 at the XXI Portugal-Spain Summit, in Évora, whereby the two Governments made clear their commitment to a strong cooperation in ambitious science and technology joint ventures for the future.INL will provide a state-of the art research environment promoting an interdisciplinarity effort in addressing the major challenges in the emerging areas of Nanobiotechnology, Nanoelectronics, Nanomedicine and Materials Science at Nanoscale. The key research activities are based on existing areas of excellence in Portugal and Spain, as well as on new strategic development areas where researchers will be hired. The combination of an appropriate level of available research funds, internationally competitive recruiting, a state-of-the-art research facility, and an innovative and entrepreneur attitude in our organizational value will be the major factors in attracting leading scientists and young and promising researchers to join the founding research team of INL. The Laboratory is planned for 200 scientists, about 100 PhD students, and supporting technical and administrative staff.INL will closely work with international research centers, local and global industry and universities under an open innovation approach, aiming to pursue a thriving society and social wellbeing. Wikipedia.
Fernandez Rossier J.,International Iberian Nanotechnology Laboratory
Nature Materials | Year: 2013
A series of breakthroughs is making the fabrication of single-atom devices possible. Their behavior is controlled by the quantum state of single dopants, and they hold promise for applications such as quantum bits, magnetometers and memories. However, for conventional architectures the reduction of the number of dopants also presents a design problem: below a certain threshold, their statistical fluctuation becomes comparable in magnitude to the actual number of dopants in the device itself. This makes nominally identical devices behave differently. In contrast, proposals such as the Kane quantum computer use the nuclear spin of individual phosphorus donor atoms embedded in silicon as a qubit. To make the jump from single qubits to fully fledged quantum computers, control over the spin coupling between individual dopants is essential. Source
Liu L.,International Iberian Nanotechnology Laboratory
Nanoscale | Year: 2013
Nano-aggregates of cobalt nickel oxysulfide (CoNi)OxS y have been synthesized by hydrothermal processing and exhibited specific and areal capacitance as high as 592 F g-1 and 1628 mF cm-2, respectively, at a current density of 0.5 A g -1/1.375 mA cm-2. They also show high capacitance retention upon extended cycling at high rates. © 2013 The Royal Society of Chemistry. Source
Liu L.,International Iberian Nanotechnology Laboratory
Journal of Power Sources | Year: 2013
Porous Co16S16O96 (COD database code: 591-0314) nanosheets have been fabricated by a simple and low-cost hydrothermal approach. The as-fabricated Co16S16O96 nanostructures are characterized by a porous interconnected sheet-like network and prove to be highly crystalline. Electrochemical tests reveal that the Co16S16O96 nanosheets can be reversibly charged and discharged in a potential window between -0.05 and 0.4 V vs. saturated calomel electrode at various specific current densities ranging from 0.5 A g-1 to 50 A g-1. The specific capacitance of these nanosheets is 333 F g-1 at 1 A g-1 in the beginning of cycling test, and increases with cycle numbers up to 386 F g-1, then remaining constant till 4000 cycles. More remarkably, even at a current density as high as 50 A g-1, the nanosheets still possess a specific capacitance of 170 F g-1, and only lose 15.3% of the initial capacitance value after 4000 cycles, showing great promise for use as high-performance supercapacitor electrodes. © 2013 Elsevier B.V. All rights reserved. Source
International Iberian Nanotechnology Laboratory | Date: 2014-03-26
Agency: Cordis | Branch: H2020 | Program: RIA | Phase: NMP-12-2015 | Award Amount: 7.78M | Year: 2016
Alzheimers disease (AD) is the leading cause of dementia and loss of autonomy in the elderly, implying a progressive cognitive decline and limitation of social activities. Progressive aging of EU population will increase the magnitude of this problem in the next decades. Currently, there is not an effective method for the early diagnosis of AD. Therefore, there is an urgent need to develop new effective early diagnostic and therapeutic strategies to help in delaying the appearance of the most adverse symptoms of this disease. To defeat this challenge, PANA project bases its approach on the importance of tau oligomers in the early pathophysiological processes of AD. The effective strategy will be based on two fundamental pillars; on one hand, efforts will be focused on multimodal PET/MRI imaging which is gaining relevance as the best solution for diagnostic purposes due to the complementary advantages of both technologies, combining the high structural characterization of tissue provided by MRI with the enhanced sensitivity of PET imaging. On the other hand, the challenging development of a theragnostic nanostructures will be focused on tau oligomers detection, which would have to deliver theragnostic agents into the brain to provide in situ diagnostic and therapeutic effects. Therefore, PANA project focuses on developing theranostic nanostructures that specifically recognize very-early molecular markers of AD, and can be detected by means of non-invasive imaging methodologies (MRI and/or PET, which are already common techniques accessible in most hospitals) and eventually provide a therapeutic action if needed. To achieve this goal, we propose a unique consortium which combines neuroscientists, nanotechnologists, molecular imaging experts, clinicians and Small/Medium/Large Enterprises in an effort to use smart nanoparticles engineered with multifunctional biomaterial to provide new very-early diagnostic tools for AD, a vital medical/social problem in EU.